Member News

Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells Asymmetrex, LLC May 21, 2019

Asymmetrex approved by the ASTM International to conduct an interlab evaluation of its AlphaSTEM Test™ stem cell-specific counting technology as a standard for the stem cell medicine industry. Read More

Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells Asymmetrex, LLC May 16, 2019

In November 2018, Asymmetrex presented its stem cell counting technology to ASTM staff for evaluation as an ASTM standard. Today, the company presented a proposal for an interlab study of its test. Read More

Queensland Biomedical Voucher Program Australian Trade and Investment Commission April 9, 2019

Queensland state government will match A$250,000 (approx. $180,000 USD) for biomedical product development collaboration in Queensland. Contact Austrade to learn more. elizabeth.thomas@austrade.gov.au Read More

Queensland Biomedical Voucher Program Australian Trade and Investment Commission April 9, 2019

Queensland state government will match A$250,000 (approx. $180,000 USD) for biomedical product development collaboration in Queensland. Contact Austrade to learn more. elizabeth.thomas@austrade.gov.au Read More

Asymmetrex Intensifies Campaign to Increase Awareness of the Adult Tissue Stem Cell Counting Problem Asymmetrex, LLC November 7, 2018

On November 6, in an essay on the clinicaltrialsarena.com News website, Asymmetrex’s director compares the stem cell counting problem to the “Emperor’s New Clothes” to highlight Asymmetrex’s solution. Read More

Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players EvaluatePharma USA, Inc. October 3, 2018

The global medtech industry is forecast to grow at a CAGR of 5.6% from 2017 to 2024 and reach $595 billion in sales by 2024, according to the latest report from Evaluate Ltd. Read More

An Important Medical Device Regulation Update from Australia Australian Trade and Investment Commission September 4, 2018

In an exciting development for North American companies, the TGA, Australia’s regulatory body for therapeutic goods, has released new guidance on accepted overseas approvals on medical devices. Read More

Small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers EvaluatePharma USA, Inc. August 28, 2018

The first half of 2018 has seen biopharma IPOs and venture financing accelerate from the already-healthy levels witnessed in 2017. Deal making has dimmed further, however, raising concern. Read More